HOME >> BIOLOGY >> NEWS
Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

ed States Representative (N.Y.)

  • The Honorable Joseph L. Bruno, New York State Senate Majority Leader

  • The Honorable Elias Zerhouni, M.D., Director, National Institutes of Health

  • Bruce Alberts, Ph.D. President, National Academy of Sciences

  • Samuel Heffner Jr. '56, Chairman, Board of Trustees, Rensselaer Polytechnic Institute

  • Howard P. Isermann '42, Honorary Trustee, Rensselaer Polytechnic Institute

  • Robert E. Palazzo, Ph.D., Acting Director, Center for Biotechnology and Interdisciplinary Studies and Chair, Department of Biology, Rensselaer Polytechnic Institute

    "This extraordinary group of leaders in the sciences, engineering, business and government is rarely assembled in one place, and their participation is a testament to what the Rensselaer community has accomplished in a few short years," said Rensselaer President Shirley Ann Jackson. "By establishing the Center for Biotechnology and Interdisciplinary Studies, we have created a gathering place where scientists and engineers from various disciplines will explore at the intersection of the life sciences, with engineering and the physical and information sciences, thereby accelerating discovery and ultimately enhancing the quality of life for all people."

    Rensselaer's new center ranks among the world's most advanced research facilities focused on the application of engineering and the physical and information sciences to the life sciences. The Center for Biotechnology and Interdisciplinary Studies is a 218,000-square-foot, $100 million facility (including $80 million for construction). With its high-tech laboratories and expansive atrium, it provides a platform for collaboration among many diverse academic and research disciplines to enhance discovery and encourage innovation.

    The Center is designed to foster the multidisciplinary nature of biotechnology. It is organized around "constellations" of research Biocomputation and Bioin
    '"/>



  • Contact: Theresa Bourgeois
    bourgt@rpi.edu
    518-276-2840
    Rensselaer Polytechnic Institute
    2-Sep-2004


    Page: 1 2 3 4

    Related biology news :

    1. Rensselaer receives NIH grant to develop virtual surgery simulator
    2. New software developed at Rensselaer predicts promising ingredients for new drugs
    3. Rensselaer awarded $2.7 million NIH grant to improve drug development process
    4. National Institutes of Health grant to Rensselaer to further research on healing bone injuries
    5. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
    6. Rensselaer effort to pull mussels at Lake George looks promising
    7. NASA Funds New Origin Of Life Center at Rensselaer Polytechnic Institute
    8. X marks the spot: Vector insertion is viral specific
    9. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
    10. High Flux Isotope Reactor marks 400th cycle
    11. Study marks increased trends in infectious disease occurrences in our oceans

    Post Your Comments:
    (Date:12/19/2014)... Dec. 18, 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ... Monitor: North America Perimeter Security Systems Market" report to ... The North American perimeter security market is estimated to ... Although the U.S. market holds a larger share in this ...
    (Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 Based ... 5S, Samsung introduces for the first time a fingerprint ...
    (Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
    Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
    (Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
    (Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
    (Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
    (Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn cases ... Syngenta, are in the process of being consolidated in a ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... Kansas. , Management of the Syngenta GMO corn multidistrict litigation ...
    Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
    Cached News: